OSCR - Oscar Health, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$18.75
DETAILS
HIGH:
$21.00
LOW:
$16.00
MEDIAN:
$19.00
CONSENSUS:
$18.75
DOWNSIDE:
17.18%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 11,701.4 | 9,177.6 | 5,862.9 | 4,125.6 | 1,921.0 | 589.6 | 553.8 |
| Cost of Revenue | 10,019.0 | 7,332.6 | 4,642.0 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,682.4 | 1,845.0 | 1,220.8 | 4,125.6 | 1,921.0 | 589.6 | 553.8 |
| Operating Expenses | |||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 2,049.9 | 0 | 0 | 1,419.4 | 265.1 | 166.7 | 110.7 |
| Other Expenses | 28.9 | 1,787.7 | 1,456.5 | 3,316.3 | 2,226.5 | 828.8 | 702.5 |
| Operating Expenses | 2,078.8 | 1,787.7 | 1,456.5 | 4,735.7 | 2,491.5 | 995.4 | 813.2 |
| Operating Income | |||||||
| Operating Income | (396.4) | 57.3 | (235.6) | (610.1) | (570.6) | (405.8) | (259.4) |
| Interest Expense | 17.6 | 23.7 | 24.6 | 22.6 | 4.7 | 3.5 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 11.1 |
| Profitability | |||||||
| EBITDA | (391.1) | 89.3 | (212.0) | (572.2) | (551.3) | (391.0) | (252.5) |
| EBIT | (419.7) | 57.2 | (242.7) | (587.5) | (565.9) | (402.3) | (259.4) |
| Income Before Tax | (437.3) | 33.4 | (267.3) | (610.1) | (570.6) | (405.8) | (259.4) |
| Income Tax Expense | 5.6 | 7.3 | 3.3 | (0.5) | 0.8 | 1.0 | 1.8 |
| Net Income | (443.2) | 25.4 | (270.7) | (606.3) | (572.6) | (406.8) | (261.2) |
| Per Share Data | |||||||
| EPS (Basic) | -1.69 | 0.11 | -1.22 | -2.85 | -3.19 | -1.70 | -8.93 |
| EPS (Diluted) | -1.69 | 0.10 | -1.22 | -2.85 | -3.19 | -1.70 | -1.09 |
| Shares Outstanding | 262.4 | 240.4 | 221.7 | 212.5 | 179.0 | 239.3 | 29.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 2,774.2 | 1,527.2 | 1,870.3 | 1,558.6 | 1,104.0 | 826.3 | 336.6 |
| Short-Term Investments | 1,216.5 | 624.5 | 689.8 | 1,397.3 | 587.1 | 366.4 | 333.8 |
| Net Receivables | 442.6 | 315.9 | 494.4 | 49.9 | 611.1 | 96.5 | 55.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 180.1 | 377.6 | (983.0) | 1,115.8 | 463.9 | (1,289.2) | (725.6) |
| Total Current Assets | 4,613.4 | 2,845.2 | 2,071.6 | 4,121.6 | 2,766.0 | 0 | 0 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 88.3 | 66.8 | 61.9 | 59.9 | 46.6 | 35.8 | 33.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1,471.0 | 1,815.3 | 365.3 | 1,397.3 | 844.5 | 366.4 | 333.8 |
| Other Non-Current Assets | 152.7 | 113.3 | 1,102.7 | (1,052.1) | (335.4) | (402.2) | (366.8) |
| Total Non-Current Assets | 1,712.0 | 1,995.3 | 1,529.9 | 405.0 | 555.6 | 0 | 0 |
| Total Assets | 6,325.4 | 4,840.5 | 3,601.5 | 4,526.6 | 3,321.7 | 2,272.1 | 1,346.9 |
| Current Liabilities | |||||||
| Account Payables | (99.8) | 1,398.1 | 1,027.0 | 1,365.4 | 718.8 | 655.2 | 589.1 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 75.0 | 0 | 0 |
| Other Current Liabilities | 4,962.3 | 215.3 | (2,259.2) | 381.1 | 29.2 | (1,371.6) | (887.7) |
| Total Current Liabilities | 4,862.6 | 3,171.7 | (175.3) | 3,263.9 | 1,617.5 | 0 | 0 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 430.1 | 299.6 | 298.8 | 298.0 | 0 | 142.5 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 4.1 | 0 | 0 |
| Other Non-Current Liabilities | 52.0 | 61.3 | 2,671.9 | 72.3 | 2,286.1 | (142.5) | 0 |
| Total Non-Current Liabilities | 482.1 | 360.8 | 2,970.6 | 370.3 | 2,290.2 | 0 | 0 |
| Total Liabilities | 5,344.7 | 3,824.1 | 2,795.4 | 3,634.2 | 1,929.1 | 3,568.0 | 2,292.1 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (3,294.4) | (2,851.3) | (2,876.7) | (2,606.0) | (1,999.7) | (1,427.1) | (1,012.9) |
| Accumulated Other Comprehensive Income | 18.0 | (1.8) | 1.3 | (9.7) | (3.7) | 0.9 | (0.0) |
| Total Stockholders' Equity | 977.6 | 1,013.6 | 804.0 | 890.4 | 1,387.2 | (1,295.9) | (945.1) |
| Total Liabilities & Equity | 6,325.4 | 4,840.5 | 3,601.5 | 4,526.6 | 3,321.7 | 2,272.1 | 1,346.9 |
| Debt Metrics | |||||||
| Total Debt | 430.1 | 299.6 | 298.8 | 298.0 | 0 | 142.5 | 0 |
| Net Debt | (2,344.1) | (1,227.6) | (1,571.5) | (1,260.6) | (1,104.0) | (683.8) | (336.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (442.9) | 26.1 | (270.6) | (609.6) | (571.4) | (406.8) | (261.2) |
| Depreciation & Amortization | 28.9 | 32.1 | 30.7 | 15.3 | 14.6 | 11.3 | 6.9 |
| Stock-Based Compensation | 87.7 | 109.8 | 159.7 | 112.3 | 86.3 | 35.9 | 33.6 |
| Change in Working Capital | 1,459.0 | 838.9 | (192.1) | 855.0 | 247.7 | 575.7 | 62.2 |
| Other Non-Cash Items | (40.2) | (26.4) | 0.1 | 7.5 | 41.2 | 6.8 | (6.4) |
| Operating Cash Flow | 1,094.9 | 978.2 | (272.2) | 380.3 | (181.7) | 222.7 | (165.4) |
| Investing Activities | |||||||
| Capital Expenditure | (36.4) | (27.9) | (25.6) | (29.0) | (25.9) | (14.0) | (26.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 7.2 | 0 | 0 |
| Purchases of Investments | (1,013.9) | (2,133.5) | (837.0) | (1,192.7) | (1,810.1) | (1,001.0) | (877.7) |
| Sales/Maturities of Investments | 805.0 | 770.0 | 1,442.0 | 994.1 | 1,054.8 | 671.6 | 1,061.3 |
| Other Investing Activities | 4.3 | 3.9 | (2.3) | 1.1 | (0.6) | (1.2) | (7.1) |
| Investing Cash Flow | (241.1) | (1,387.4) | 577.2 | (226.5) | (774.5) | (344.7) | 150.5 |
| Financing Activities | |||||||
| Net Debt Issuance | 348.2 | 0 | 0 | 305 | (153.2) | 147 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | (3.0) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.0) | 0 | 2.5 | (5.2) | 43.6 | 89.0 | 0.9 |
| Financing Cash Flow | 399.2 | 68.4 | 6.4 | 301.1 | 1,238.7 | 611.7 | (2.1) |
| Cash Position | |||||||
| Net Change in Cash | 1,253.0 | (340.9) | 311.5 | 454.9 | 282.5 | 489.7 | (17.0) |
| Cash at Beginning | 1,551.1 | 1,892.0 | 1,580.5 | 1,125.6 | 843.1 | 353.4 | 370.4 |
| Cash at End | 2,804.1 | 1,551.1 | 1,892.0 | 1,580.5 | 1,125.6 | 843.1 | 353.4 |
| Free Cash Flow | 1,058.5 | 950.3 | (297.7) | 351.3 | (207.6) | 208.7 | (191.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 11,701.4 | 9,177.6 | 5,862.9 | 4,125.6 | 1,921.0 | 589.6 | 553.8 |
| Gross Profit | 1,682.4 | 1,845.0 | 1,220.8 | 4,125.6 | 1,921.0 | 589.6 | 553.8 |
| Operating Income | (396.4) | 57.3 | (235.6) | (610.1) | (570.6) | (405.8) | (259.4) |
| Net Income | (443.2) | 25.4 | (270.7) | (606.3) | (572.6) | (406.8) | (261.2) |
| EPS (Diluted) | -1.69 | 0.10 | -1.22 | -2.85 | -3.19 | -1.70 | -1.09 |
| Balance Sheet | |||||||
| Cash & Equivalents | 2,774.2 | 1,527.2 | 1,870.3 | 1,558.6 | 1,104.0 | 826.3 | 336.6 |
| Total Assets | 6,325.4 | 4,840.5 | 3,601.5 | 4,526.6 | 3,321.7 | 2,272.1 | 1,346.9 |
| Total Debt | 430.1 | 299.6 | 298.8 | 298.0 | 0 | 142.5 | 0 |
| Stockholders' Equity | 977.6 | 1,013.6 | 804.0 | 890.4 | 1,387.2 | (1,295.9) | (945.1) |
| Cash Flow | |||||||
| Operating Cash Flow | 1,094.9 | 978.2 | (272.2) | 380.3 | (181.7) | 222.7 | (165.4) |
| Capital Expenditure | (36.4) | (27.9) | (25.6) | (29.0) | (25.9) | (14.0) | (26.0) |
| Free Cash Flow | 1,058.5 | 950.3 | (297.7) | 351.3 | (207.6) | 208.7 | (191.4) |